Tuesday November 24 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Hemosol Incorporated


Contact Details:
115 Skyway Avenue
Etobicoke
Ontario
M9W 4Z4
Canada
Tel:416 798 0700
Fax:416 798 0151
Email:
WWW:

www.hemosol.com/




Loading...

Recent Publications by Hemosol Incorporated:

Expression of the hemoglobin-haptoglobin receptor CD163 on hematopoietic progenitors.
CD163, the hemoglobin-haptoglobin receptor, has been reported to be...
19th July, 2006
Hemosol LP, Mississauga, ON, Canada L5N 8H9. Stem Cells Dev. 2006 Feb;15(1):40-8.
DOI Direct Link
Synthesis and characterization of a hemoglobin-ribavirin conjugate for targeted drug delivery.
A novel conjugate of human hemoglobin (Hb) and the nucleoside analogue...
13th July, 2006
Hemosol Corporation, 2585 Meadowpine Boulevard, Mississauga, Ontario, Bioconjug Chem. 2006 Mar-Apr;17(2):530-7.
DOI Direct Link
The intravascular persistence and methemoglobin formation of Hemolink (hemoglobin raffimer) in dogs.
Hemoglobin raffimer (HEMOLINK, Hemosol Inc, Mississauga, Canada) is an...
15th October, 2003
Hemosol Inc., Mississauga, Ontario, Canada. Artif Cells Blood Substit Immobil Biotechnol. 2003 Feb;31(1):1-17.
Targeted RNA recombination of the membrane and nucleocapsid protein genes between mouse hepatitis virus and bovine coronavirus.
The targeted RNA recombination was attempted to substitute the membrane...
5th March, 2003
Department of Pathology, Ontario Veterinary College, University of Guelph, J Vet Sci. 2001 Dec;2(3):149-57.
A phase I study of oxidized raffinose cross-linked human hemoglobin.
OBJECTIVE: To evaluate the safety of oxidized-raffinose cross-linked human...
19th August, 2000
Clinical Affairs Division of Hemosol Inc., Toronto, ON, Canada. Crit Care Med. 2000 Jul;28(7):2283-92.

View more Hemosol Incorporated research publications.

Hemosol Incorporated Clinical Trials:

Phase II Study To Evaluate The Safety and Efficacy of Hemoglobin Raffimer in Patients Undergoing First Time CABG Surgery

Hemosol Incorporated Patents:

US Patent No.Title
6974794 Hemoglobin-antioxidant conjugates
5532352 Selective crosslinking of hemoglobin by oxidized, ring-opened saccharides
5545328 Purification of hemoglobin by displacement chromatography
5770727 Crosslinked hemoglobin product comprising tetrameric and oligomeric hemoglobin units
6194207 Methods for the selective expansion of lymphocytes by in vitro cultivation

View more Hemosol Incorporated patents.

Hemosol Incorporated (HMSL) Financial information Links from Barchart

HMSL Quote from from Barchart.com
HMSL Chart from from Barchart.com
HMSL Profile from from Barchart.com
HMSL Opinion from from Barchart.com

View more Hemosol Incorporated finance information.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 724 times since April 2007, the link to the organisation's website has been followed 157 times

Recent Search Terms used to find this page: hemosol canada | hemosol inc. Canada | hemosol inc. Canada | hemosol mississauga | hemosol canada | hemosol inc 2009 what happened | Hemosol Corporation | hemosol canada | HEMOSOL CORPORATION website | hemosol canada | .

Search for more companies in Etobicoke

Search for more companies in Ontario



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Hemosol Incorporated

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.